The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: Possible therapy for optic neuropathies
Open accessAbstract
We recently reported that the posttraumatic spread of degeneration in the damaged optic nerve can be attenuated by the adoptive transfer of autoimmune T cells specific to myelin basic protein. However, it would be desirable to obtain immune neuroprotection free of any possible autoimmune disease. In an attempt to obtain disease-free immune neuroprotection, we used the synthetic four-amino acid polymer copolymer 1 (Cop-1), which is known not to be encephalitogenic despite its cross-reactivity with myelin basic protein. We show here that active immunization with Cop-1 administered in adjuvant, as well as adoptive transfer of T cells reactive to Cop-1, can inhibit the progression of secondary degeneration after crush injury of the rat optic nerve. These results have implications for the treatment of optic neuropathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for Activity
Gillis, S., Ferm, M. M., Ou, W., & Smith, K. A. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.120.6.2027 · Cited by 3,273
T‐lymphocyte entry into the central nervous system
Hickey, W. F., Hsu, B. L., & Kimura, H. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490280213 · Cited by 1,177
Kerschensteiner, M., Gallmeier, E., Behrens, L., Leal, V. V., Misgeld, T., Klinkert, W. E. F., Kolbeck, R., Hoppe, E., Oropeza-Wekerle, R.-L., Bartke, I., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.865 · Cited by 1,019
Ben‐Nun, A., Wekerle, H., & Cohen, I. R. (1981) · European Journal of Immunology · doi:10.1002/eji.1830110307 · Cited by 916
Self-citationAutoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy
Moalem, G., Leibowitz–Amit, R., Yoles, E., Mor, F., Cohen, I. R., & Schwartz, M. (1999) · Nature Medicine · doi:10.1038/4734 · Cited by 889
Self-citationOral tolerance: immune mechanisms and treatment of autoimmune diseases
Weiner, H. L. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01053-0 · Cited by 731
Sendtner, M., Holtmann, B., Kolbeck, R., Thoenen, H., & Barde, Y.-A. (1992) · Nature · doi:10.1038/360757a0 · Cited by 707
Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death
Yan, Q., Elliott, J., & Snider, W. D. (1992) · Nature · doi:10.1038/360753a0 · Cited by 661
Hünig, T., Wallny, H. J., Hartley, J. K., Lawetzky, A., & Tiefenthaler, G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.73 · Cited by 451
Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide
Teitelbaum, D., Meshorer, A., Hirshfeld, T., Arnon, R., & Sela, M. (1971) · European Journal of Immunology · doi:10.1002/eji.1830010406 · Cited by 433
Self-citationInnate and adaptive immune responses can be beneficial for CNS repair
Schwartz, M., Moalem, G., Leibowitz-Amit, R., & Cohen, I. R. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01405-8 · Cited by 341
Self-citationAharoni, R., Teitelbaum, D., Sela, M., & Arnon, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10821 · Cited by 274
Self-citationBen-Nun, A., & Cohen, I. R. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.1.303 · Cited by 261
Self-citationYoles, E., & Schwartz, M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6811 · Cited by 214
Self-citationAutoimmune T cells as potential neuroprotective therapy for spinal cord injury
Hauben, E., Nevo, U., Yoles, E., Moalem, G., Agranov, E., Mor, F., Akselrod, S., Neeman, M., Cohen, I., & Schwartz, M. (2000) · The Lancet · doi:10.1016/s0140-6736(99)05140-5 · Cited by 213
Self-citationORAL TOLERANCE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
Weiner, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.341 · Cited by 191
Aharoni, R., Teitelbaum, D., Sela, M., & Arnon, R. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00166-0 · Cited by 173
Self-citationJonas, J. B., & Budde, W. M. (2000) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(99)00002-6 · Cited by 166
Teitelbaum, D., Fridkis‐Hareli, M., Arnon, R., & Sela, M. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00180-8 · Cited by 153
Self-citationMoalem‐Taylor, G., Monsonego, A., Shani, Y., Cohen, I. R., & Schwartz, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.10.1207 · Cited by 152
Self-citationSpecific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1.
Teitelbaum, D., Aharoni, R., Arnon, R., & Sela, M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9724 · Cited by 113
Self-citationBen‐Nun, A., Mendel, I., Bakimer, R., Fridkis‐Hareli, M., Teitelbaum, D., Arnon, R., Sela, M., & de Rosbo, N. K. (1996) · Journal of Neurology · doi:10.1007/bf00873697 · Cited by 105
Self-citationPotential Neuroprotective Therapy for Glaucomatous Optic Neuropathy
Yoles, E., & Schwartz, M. (1998) · Survey of Ophthalmology · doi:10.1016/s0039-6257(97)00123-9 · Cited by 100
Self-citationPotential treatment modalities for glaucomatous neuropathy: neuroprotection and neuroregeneration.
Schwartz, M., Belkin, M., Yoles, E., et al. (1996) · PubMed · Cited by 94
Self-citationHirschberg, D. L., Moalem‐Taylor, G., He, J., Mor, F., Cohen, I. R., & Schwartz, M. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00118-0 · Cited by 91
Self-citationAutoimmune T cells retard the loss of function in injured rat optic nerves
Moalem‐Taylor, G., Yoles, E., Leibowitz‐Amit, R., Muller-Gilor, S., Mor, F., Cohen, I. R., & Schwartz, M. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00240-x · Cited by 90
Self-citationAharoni, R., Teitelbaum, D., & Arnon, R. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230105 · Cited by 86
Neuroprotection: a new treatment modality for glaucoma?
Schwartz, M., & Yoles, E. (2000) · Current Opinion in Ophthalmology · doi:10.1097/00055735-200004000-00007 · Cited by 39
Self-citationCopolymer 1 from the laboratory to FDA.
Teitelbaum, D., Sela, M., & Arnon, R. (1997) · PubMed · Cited by 21
Self-citation
Cited by
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Weinreb, R. N., & Khaw, P. T. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16257-0 · Cited by 2,222
The retina as a window to the brain—from eye research to CNS disorders
London, A., Benhar, I., & Schwartz, M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.227 · Cited by 1,403
Self-citationKipnis, J., Cohen, H., Cardon, M., Ziv, Y., & Schwartz, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402268101 · Cited by 510
Self-citationMicroglial phenotype: is the commitment reversible?
Schwartz, M., Butovsky, O., Brück, W., & Hanisch, U.-K. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2005.12.005 · Cited by 434
Self-citation
Metadata
- Authors
- Kipnis, J., Yoles, E., Porat, Z., Cohen, A., Mor, F., Sela, M., Cohen, I. R., & Schwartz, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-06-20
- Volume
- 97
- Issue
- 13
- Pages
- 7446-7451
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2063986567
- Cited by
- 308
- References
- 29
- FWCI
- 15.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.